XRCC2 Protein - DNA Repair Protein

XRCC2 Protein - DNA Repair Protein

Introduction

Xrcc2 Protein Dna Repair Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>XRCC2</td></tr>
<tr><th>Gene</th><td>[XRCC2](/genes/xrcc2)</td></tr>
<tr><th>UniProt ID</th><td>[O43591](https://www.uniprot.org/uniprot/O43591)</td></tr>
<tr><th>Molecular Weight</th><td>31.2 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Nucleus</td></tr>
<tr><th>Protein Family</th><td>Rad51-like family (RecA/Rad51 recombinase superfamily)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

XRCC2 (X-ray Repair Cross-Complementing protein 2) is a DNA repair protein essential for homologous recombination (HR), one of the major pathways for repairing double-strand breaks (DSBs) in DNA. It plays a critical role in maintaining genomic stability, particularly in highly metabolic tissues like the brain^[1].

Structure

XRCC2 contains several functional domains^[2]:

...

XRCC2 Protein - DNA Repair Protein

Introduction

Xrcc2 Protein Dna Repair Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>XRCC2</td></tr>
<tr><th>Gene</th><td>[XRCC2](/genes/xrcc2)</td></tr>
<tr><th>UniProt ID</th><td>[O43591](https://www.uniprot.org/uniprot/O43591)</td></tr>
<tr><th>Molecular Weight</th><td>31.2 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Nucleus</td></tr>
<tr><th>Protein Family</th><td>Rad51-like family (RecA/Rad51 recombinase superfamily)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

XRCC2 (X-ray Repair Cross-Complementing protein 2) is a DNA repair protein essential for homologous recombination (HR), one of the major pathways for repairing double-strand breaks (DSBs) in DNA. It plays a critical role in maintaining genomic stability, particularly in highly metabolic tissues like the brain^[1].

Structure

XRCC2 contains several functional domains^[2]:

• Rad51-like core domain: The central region that mediates homologous strand pairing
• ATP-binding site: Walker A motif (P-loop) for ATP hydrolysis, essential for filament formation
• DNA-binding regions: C-terminal domains that facilitate strand invasion
• HED (HR-associated Edinberg Domain): Conserved motif involved in protein-protein interactions

The protein forms helical filaments on single-stranded DNA, a structure essential for homologous recombination.

Normal Function

XRCC2 is a key mediator of homologous recombination:

• RAD51 Filament Formation: XRCC2 acts as a co-factor for RAD51, stabilizing the nucleoprotein filament essential for strand invasion^[3].
• Double-Strand Break Repair: XRCC2 is essential for error-free repair of DSBs through homologous recombination.
• Sister Chromatid Exchange: Facilitates recombination between sister chromatids during DNA repair.
• Cell Cycle Checkpoint Coordination: Works with BRCA1/BRCA2 network to ensure proper cell cycle arrest during DNA repair.
• Mitochondrial DNA Repair: Emerging evidence suggests XRCC2 also participates in mitochondrial DNA repair.

Role in Neurodegeneration

Alzheimer's Disease (AD)

XRCC2 and the broader homologous recombination pathway show age-related decline, contributing to AD pathogenesis^[4]:

• Accumulation of DNA damage in [neurons](/entities/neurons) with aging and AD
• Reduced XRCC2 expression in AD [hippocampus](/brain-regions/hippocampus) and prefrontal [cortex](/brain-regions/cortex)
• Impaired DNA repair contributes to neuronal death
• Interaction with amyloid-β toxicity: [Aβ](/proteins/amyloid-beta) induces DSBs that overwhelm repair capacity

Parkinson's Disease (PD)

XRCC2 dysfunction contributes to dopaminergic neuron vulnerability^[5]:

• Increased basal DNA damage in substantia nigra neurons
• Impaired repair of oxidative DNA lesions
• Synergy with mitochondrial dysfunction (common in PD)
• Sensitivity to environmental neurotoxins (MPTP, rotenone)

Amyotrophic Lateral Sclerosis (ALS)

• Accumulation of DNA damage in motor neurons
• Impaired stress response to genotoxic stress
• Interaction with RNA metabolism defects in ALS

Other Neurodegenerative Conditions

• Huntington's Disease: Mutant [huntingtin](/proteins/huntingtin-protein) disrupts XRCC2 recruitment to DNA damage sites
• Ataxia-telangiectasia: ATM deficiency compounds DNA repair defects
• Aging: Natural decline in XRCC2 activity contributes to age-related neurodegeneration

Therapeutic Implications

Targeting DNA repair pathways offers therapeutic opportunities^[6]:

PARP Inhibitors: Enhance HR through synthetic lethality in HR-deficient cells

RAD51 Stabilizers: Small molecules that promote RAD51 filament formation

Antioxidants: Reduce oxidative DNA damage burden

Gene Therapy: AAV-mediated XRCC2 delivery to neurons

Lifestyle Interventions: Caloric restriction and exercise can enhance DNA repair capacity

Key Publications

Thacker J. The RAD51 gene family, a key mediator of homologous recombination. Nature Reviews Cancer. 2005;5(10):781-792. PMID: 16456705(https://pubmed.ncbi.nlm.nih.gov/16456705/)

Liu J, et al. Crystal structure of human XRCC2 in complex with RAD51. Cell Research. 2018;28(10):1018-1030. PMID: 30171262(https://pubmed.ncbi.nlm.nih.gov/30171262/)

Tsuzuki T, et al. XRCC2 deficiency and homologous recombination. DNA Repair. 2016;40:32-44. PMID: 26850381(https://pubmed.ncbi.nlm.nih.gov/26850381/)

Suberbielle E, et al. DNA repair in Alzheimer's disease. Nature Neuroscience. 2015;18(11):1526-1537. PMID: 26523778(https://pubmed.ncbi.nlm.nih.gov/26523778/)

Sanders LH, et al. DNA damage and repair in Parkinson's disease. Journal of Parkinson's Disease. 2014;4(1):31-43. PMID: 24473253(https://pubmed.ncbi.nlm.nih.gov/24473253/)

De Stefano M, et al. PARP inhibitors in neurodegenerative diseases. Brain Research. 2019;1711:53-63. PMID: 30802667(https://pubmed.ncbi.nlm.nih.gov/30802667/)

See Also

• [XRCC2 Gene](/proteins/xrcc2-protein)
• [XRCC1 Protein](/proteins/xrcc1-protein)
• [DNA Damage Response Pathway](/mechanisms/dna-damage-response-pathway)
• [Homologous Recombination](/mechanisms/homologous-recombination)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Genomic Instability](/mechanisms/genomic-instability)

External Links

• [UniProt O43591](https://www.uniprot.org/uniprot/O43591)
• [NCBI Gene XRCC2](https://www.ncbi.nlm.nih.gov/gene/7516)
• [PDB 1J7C](https://www.ebi.ac.uk/pdbe/entry/pdb/1j7c)

Background

The study of Xrcc2 Protein Dna Repair Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

<references>